Dr. Stephanie Tsai
Claim this profileLoyola University Medical Center
Studies Leukemia
Studies Lymphoblastic Leukemia-Lymphoma
10 reported clinical trials
23 drugs studied
Area of expertise
1Leukemia
BCR-ABL1 positive
CD22 positive
Philadelphia chromosome positive
2Lymphoblastic Leukemia-Lymphoma
BCR-ABL1 positive
CD22 positive
Philadelphia chromosome positive
Affiliated Hospitals
Clinical Trials Stephanie Tsai is currently running
Inotuzumab Ozogamicin + Chemotherapy
for Leukemia and Lymphoma
This trial tests a new treatment combining inotuzumab ozogamicin with chemotherapy for patients with certain types of blood cancer. The new drug targets cancer cells directly and delivers a toxin to kill them. This approach aims to improve the effectiveness of treatment compared to standard chemotherapy alone. Inotuzumab ozogamicin has shown superior efficacy compared to conventional chemotherapy in patients with specific types of blood cancer.
Recruiting3 awards Phase 2
Blinatumomab + Chemotherapy
for Leukemia
This phase III trial compares the effect of usual treatment of chemotherapy and steroids and a tyrosine kinase inhibitor (TKI) to the same treatment plus blinatumomab. Blinatumomab is a Bi-specific T-Cell Engager ('BiTE') that may interfere with the ability of cancer cells to grow and spread. The information gained from this study may help researchers determine if combination therapy with steroids, TKIs, and blinatumomab work better than the standard of care.
Recruiting2 awards Phase 310 criteria
More about Stephanie Tsai
Clinical Trial Related5 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Stephanie Tsai has experience with
- Blinatumomab
- Cytarabine
- Inotuzumab Ozogamicin
- Tamibarotene
- Azacitidine
- Omidubicel
Breakdown of trials Stephanie Tsai has run
Leukemia
Lymphoblastic Leukemia-Lymphoma
Lymphoid Leukemia
Acute Lymphoblastic Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Stephanie Tsai specialize in?
Stephanie Tsai focuses on Leukemia and Lymphoblastic Leukemia-Lymphoma. In particular, much of their work with Leukemia has involved BCR-ABL1 positive patients, or patients who are CD22 positive.
Is Stephanie Tsai currently recruiting for clinical trials?
Yes, Stephanie Tsai is currently recruiting for 6 clinical trials in Hines Illinois. If you're interested in participating, you should apply.
Are there any treatments that Stephanie Tsai has studied deeply?
Yes, Stephanie Tsai has studied treatments such as Blinatumomab, Cytarabine, Inotuzumab Ozogamicin.
What is the best way to schedule an appointment with Stephanie Tsai?
Apply for one of the trials that Stephanie Tsai is conducting.
What is the office address of Stephanie Tsai?
The office of Stephanie Tsai is located at: Loyola University Medical Center, Hines, Illinois 60153 United States. This is the address for their practice at the Loyola University Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.